Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions

被引：11

作者：

Woo, Julia J. ^{[1
]}

van Reekum, Emma A. ^{[2
]}

Rosic, Tea ^{[3
]}

Samaan, Zainab ^{[3
]}

机构：

[1] Univ Toronto, Fac Med, Toronto, ON, Canada

[2] McMaster Univ, Fac Med, Hamilton, ON, Canada

[3] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada

来源：

ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS | 2020年 / 11卷

关键词：

marijuana; THC; CBD; adolescents; pediatrics; MARIJUANA USE; MEDICAL MARIJUANA; NEUROPATHIC PAIN; CB1; RECEPTOR; HIGH-POTENCY; DRUG-USE; METAANALYSIS; SCHIZOPHRENIA; ASSOCIATION; OPTION;

D O I：

10.2147/AHMT.S254264

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

We provide up-to-date perspectives on the benefits and risks of medical cannabis for pain management in children and youth. To date, only two studies (a case report and a small observational study) have examined the effects of medical cannabis on pain in children and youth. No controlled trial has commented on long-term safety of medical cannabis. Findings from the recreational cannabis literature reveal significant potential short- and long-term risks of regular cannabis use, including impaired driving, depression, suicidality, psychosis, and tolerance. Despite this, many children and youth are self-medicating with cannabis, and perceive regular cannabis use to be safe. There is a need for better education and counselling of patients regarding the benefits and risks of medical cannabis use.

引用

页码：53 / 61

页数：9

共 66 条

[11] Adolescents' Use of Medical Marijuana: A Secondary Analysis of Monitoring the Future Data
Boyd, Carol J.
Veliz, Philip T.
McCabe, Sean Esteban
[J]. JOURNAL OF ADOLESCENT HEALTH, 2015, 57 (02) : 241 - 244
[12] Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions
Brown, Joshua D.
[J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
[13] Cannabis use and the development of tolerance: a systematic review of human evidence
Colizzi, Marco
Bhattacharyya, Sagnik
[J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2018, 93 : 1 - 25
[14] Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
Dalton, Victoria S.
Long, Leonora E.
Weickert, Cyndi Shannon
Zavitsanou, Katerina
[J]. NEUROPSYCHOPHARMACOLOGY, 2011, 36 (08) : 1620 - 1630
[15] High-potency cannabis and the risk of psychosis
Di Forti, Marta
Morgan, Craig
Dazzan, Paola
Pariante, Carmine
Mondelli, Valeria
Marques, Tiago Reis
Handley, Rowena
Luzi, Sonija
Russo, Manuela
Paparelli, Alessandra
Butt, Alexander
Stilo, Simona A.
Wiffen, Ben
Powell, John
Murray, Robin M.
[J]. BRITISH JOURNAL OF PSYCHIATRY, 2009, 195 (06) : 488 - 491
[16] Risk of road accident associated with the use of drugs: A systematic review and meta-analysis of evidence from epidemiological studies
Elvik, Rune
[J]. ACCIDENT ANALYSIS AND PREVENTION, 2013, 60 : 254 - 267
[17] Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles
Fedorova, Ekaterina V.
Schrager, Sheree M.
Robinson, Lucy F.
Cepeda, Alice
Wong, Carolyn F.
Iverson, Ellen
Lankenau, Stephen E.
[J]. DRUG AND ALCOHOL DEPENDENCE, 2019, 198 : 21 - 27
[18] Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice:: evidence for a "CB3" receptor
Fride, E
Foox, A
Rosenberg, E
Faigenboim, M
Cohen, V
Barda, L
Blau, H
Mechoulam, R
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 461 (01) : 27 - 34
[19] Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood A Systematic Review and Meta-analysis
Gobbi, Gabriella
Atkin, Tobias
Zytynski, Tomasz
Wang, Shouao
Askari, Sorayya
Boruff, Jill
Ware, Mark
Marmorstein, Naomi
Cipriani, Andrea
Dendukuri, Nandini
Mayo, Nancy
[J]. JAMA PSYCHIATRY, 2019, 76 (04) : 426 - 434
[20] Cannabis and Canada's children and youth
Grant, Christina N.
Belanger, Richard E.
[J]. PAEDIATRICS & CHILD HEALTH, 2017, 22 (02) : 98 - 102

← 1 2 3 4 5 6 7 →